| APC | Antigen-presenting cell |
| CTCAE | Common Terminology Criteria for Adverse Events |
| CTLA-4 | Cytotoxic T-cell lymphocyte-associated protein |
| DC | Dendritic cell |
| FMT | Fecal microbiota transplant |
| GU | Genitourinary |
| ICI | Immune checkpoint inhibitor |
| Il | Interleukin |
| irAE | Immune-related adverse event |
| MAMPs | Microorganism-associated molecular patterns |
| NSCLC | Non-small cell lung cancer |
| PD-1 | Programmed cell death 1 |
| PDL-1 | Programmed cell death 1 ligand |
| PFS | Progression-free survival |
| PRR | Pattern recognition receptors |
| RCC | Renal cell carcinoma |
| SCFA | Short chain fatty acid |
| TH | T helper |
| TLR | Toll-like receptor |
| Treg | Regulatory T cell |
| TME | Tumor microenvironment |
| UV | Ultraviolet radiation |